Technical Analysis for RGDXQ - Response Genetics

Grade Last Price % Change Price Change
grade D 0.0022 0.00% 0.0000
RGDXQ closed unchanged on Thursday, August 6, 2020, on 1.37 times normal volume. It ran into resistance at its 50 day moving average. Its advance stalled at its 200 day moving average, an important long-term support / resistance line. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a bounce should not be unexpected.

Trend Table & Recent Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Down Down Down
Historical RGDXQ trend table...

Date Alert Name Type % Chg
200 DMA Resistance Bearish 0.00%
20 DMA Resistance Bearish 0.00%
50 DMA Resistance Bearish 0.00%
Doji - Bearish? Reversal 0.00%
Doji - Bullish? Reversal 0.00%
Wide Bands Range Expansion 0.00%
Oversold Stochastic Weakness 0.00%
Narrow Range Bar Range Contraction 0.00%
Stochastic Reached Oversold Weakness 0.00%
Wide Bands Range Expansion 0.00%
Older signals for RGDXQ ...

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Response Genetics, Inc. is a life science company. The Company is engaged in the research, development, marketing and sale of pharmacogenomic tests for use in the treatment of cancer. To generate pharmacogenomic information from patient specimens for these tests, the Company uses its own methods for the extraction and analysis of nucleic acids and accessing the genetic information available from each patient sample. The Company's platforms include analysis of single biomarkers using the polymerase chain reaction method, as well as gene interrogation using microarray methods and fluorescence in situ hybridization (FISH) from paraffin or frozen tissue specimens. The Company is engaged in selling ResponseDX diagnostic testing products. The Company provides pharmacogenomic clinical trial testing services to pharmaceutical companies in the United States, Asia and Europe.
Biotechnology Branches Of Biology Cancer Life Sciences Pharmaceutical Biology Treatment Of Cancer Molecular Biology Genomics Biomarkers Dna Chip Hybridization Medical Signs Pharmacogenomics

Is RGDXQ a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Recent News

Indicators

Indicator Value
52 Week High 0.0077
52 Week Low 0.0012
Average Volume 163,776
200-Day Moving Average 0.0030
50-Day Moving Average 0.0025
20-Day Moving Average 0.0025
10-Day Moving Average 0.0026
Average True Range 0.0007
ADX 22.6
+DI 40.0000
-DI 18.4615
Chandelier Exit (Long, 3 ATRs ) 0.0016
Chandelier Exit (Short, 3 ATRs ) 0.0041
Upper Bollinger Band 0.0033
Lower Bollinger Band 0.0017
Percent B (%b) 0.31
BandWidth 64.0000
MACD Line -0.0001
MACD Signal Line -0.0002
MACD Histogram 0.0001
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 0.0034
Resistance 3 (R3) 0.0035 0.0033 0.0032
Resistance 2 (R2) 0.0033 0.0030 0.0032 0.0031
Resistance 1 (R1) 0.0027 0.0028 0.0026 0.0026 0.0031
Pivot Point 0.0025 0.0025 0.0024 0.0024 0.0025
Support 1 (S1) 0.0019 0.0022 0.0018 0.0018 0.0013
Support 2 (S2) 0.0017 0.0020 0.0016 0.0013
Support 3 (S3) 0.0011 0.0017 0.0012
Support 4 (S4) 0.0010